Ronald C. Renaud JR - President & CEO, Director at Cerevel Therapeutics Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Stock Symbol
CERE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Ronald C. Renaud JR - trading volume in the past year for Cerevel Therapeutics Holdings, Inc.

Holdings reported by Ronald C. Renaud JR for Cerevel Therapeutics Holdings, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 284,023 $12 M $42.24 Jan 19, 2024 Direct Common Stock
Common Stock 160,452 $6.78 M $42.24 Dec 19, 2023 Direct
Common Stock 83,857 $3.54 M $42.24 Dec 19, 2023 By Trust
Stock Option (Right to Buy) 215,749 Jun 12, 2023 Direct Common Stock
Performance-based Restricted Stock Units 160,371 Jun 12, 2023 Direct Common Stock

Transactions reported by Ronald C. Renaud JR for Cerevel Therapeutics Holdings, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership